Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?

This publication has 17 references indexed in Scilit:

• Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus
  Circulation, 2002
• Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
  The Lancet, 2001
• Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease
  Kidney International, 2001
• Does ADMA Cause Endothelial Dysfunction?
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Endogenous Nitric Oxide Synthase Inhibitor
  Circulation, 1999
• Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney
  Kidney International, 1997
• Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease
  Circulation, 1997
• Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits
  Biochemical and Biophysical Research Communications, 1996
• Regional and cardiac haemodynamic effects of N^G, N^G,dimethyl‐l‐arginne and their reversibility by vasodilators in conscious rats
  British Journal of Pharmacology, 1993